Influence of electrical cardioversion on troponine I and brain natriuretic peptide (NT-proBNP) levels in patients with persistent atrial fibrillation/flutter;Utjecaj elektrokonverzije na vrijednosti troponina I i moždanog natriuretskog peptida (NT-proBNP) u bolesnika s perzistentnom fibrilacijom/undulacijom atrija

Lijecnicki Vjesnik

Volumn 130, Issue 7-8, 2008, Pages 175-178

  Puljević, Mislav ^a,d   Nevajda, Branimir ^b   Sičaja, Mario ^b   Puljević, Davor ^c   Miličić, Davor ^c  

^a KBC Zagreb   (Croatia)

^b University of Zagreb School of Medicine

^c UNIVERSITY OF ZAGREB   (Croatia)

^d NONE   (Croatia)

Author keywords

Atrial fibrillation therapy; Atrial flutter therapy; Biological markers blood; Electric countershock; Natriuretic peptide, brain blood; Peptide fragments blood; Troponin I blood

Indexed keywords

EID: 53949089831     PISSN: 00243477     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Hess G, Moeck J, Zdunek D. N-terminal-pro BNP (NT-proBNP) as an indicator of cardiac dysfunction. Z Kardiol 2005;94:247-54.
2. Cheng V, Kazanagra R, Garcia A i sur. A rapid bedside test for B-type peptid predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001;37:386-91.
3. Dao Q, Krishnaswamy P, Kazanegra R i sur. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001;37:379-85.
4. Rossi A, Enriquez-Sarano M, Burnett JC, Lerman A, Abel MD, Seword JB. Natriuretic peptide levels in atrial fibrillation. J Am Coll Cardiol 2000;35:1256-62.
5. Ammann P, Pfisterer M, Fehr T, Rickli H. Raised cardiac troponins. Br Med J 2004;328:1028-9.
6. Goktekin O, Melek M, Gorenek B i sur. Cardiac troponin T and cardiac enzymes after external transthoracic cardioversion of ventricular arrhythmias in patients with coronary artery disease. Chest 2002;122:2050-4.
7. Neumayr G, Hagn C, Ganzer H i sur. Plasma levels of troponin T after electrical cardioversion of atrial fibrillation and flutter. Am J Cardiol 1997;80:1367-9.
8. Greaves K, Crake T. Cardiac troponin T does not increase after electrical cardioversion for atrial fibrillation or atrial flutter. Heart 1998;80:226-8.
9. Grulb NR, Cuthbert D, Cawood P, Flapan AD, Fox KA. Effect of DC shock on serum levels of total creatine kinase, MB-creatine kinase mass and troponin T. Resuscitation 1998;36:193-9.
10. Bonnefoy E, Chevalier P, Kirkorian G, Guidolet J, Marchand A, Touboul P. Cardiac troponin I does not increase after cardioversion. Chest 1997;111:15-8.
11. Allan LL, Feld RD, Russell AA i sur. Cardiac troponin I levels are normal or minimally elevated after transthoracic cardioversion. J Am Coll Cardiol 1997;30:1052-6.
12. Lund M, French JK, Johnson RN, Williams BF, White HD. Serum troponins T and I after elective cardioversion. Eur Hear J 2000;21:245-52.
13. Doherty PW, McLaughlin PR, Billingham M, Kernoff R, Goris ML, Harrison DC. Cardiac damage produced by direct current countershock applied to the heart. Am J Cardiol 1978;43:225-8.
14. Jakobsson J, Odmansson I, Nordlander R. Enzyme release after elective cardioversion. Eur Heart J 1990;11:749-52.
15. Stabilini R, Agostini A, Gerli GC i sur. Serum myoglobin, total CK and MB CK isoenzyme after DC cardioversion and during the early phase of acute myocardial infarction. Acta Cardiol 1980;35:373-80.
16. Vinch CS, Rashkin J, Logsetty G i sur. Brain natriuretic peptide levels fall rapidly after cardioversion of atrial fibrillation to sinus rhythm. Cardiology 2004;102:188-93.
17. Beck-da-Silva L, Bold A, Fraser M i sur. Brain natriuretic peptide levels predict successful cardioversion and rhythm maintenance in patients with atrial fibrillation. Can J Cardiol 2004;20:1245-8.
18. Yamada T, Murakami Y, Okada T i sur. Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal, persistent and permanent atrial fibrillation. Europace 2007;10:1093/eum157.
19. Kurosaki K,Tada H, Hashioto T i sur. Plasma natriuretic peptide concentations as a predictor for successful catheter alation in patients with drug refractory atrial fibrilation. Circ J 2007;71:313-20.
20. Wozakowska-Kaplon B. Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillation. Am J Cardiol 2004;92:1555-8.
21. Knudsen CW, Omland T, Clopton P i sur. Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients. J Am Coll Cardiol 2005;46:838-44.
22. Shin DI, Jaekel K, Schley Ph i sur. Plasma levels of NT-proBNP in patients with atrial fibrillation before and after electrical cardioversion. Z Kardiol 2005;94:795-800.
23. Inoue S, Murakami Y, Sano K, Katoh H, Shimada T. Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. J Card Fail 2000;6:92-6.